Advaxis collaborates with UBC to build up live attenuated Listeria vaccines Advaxis.

Under the terms of the collaboration, Dr. Kollmann shall use Advaxis proprietary Listeria vaccine vectors for the advancement of novel infectious disease applications, and employ a post-doctoral fellow who will be focused on the creation and evaluation of novel infectious disease vaccines and fresh delivery types of live attenuated Listeria vaccines.. Advaxis collaborates with UBC to build up live attenuated Listeria vaccines Advaxis, Inc., , the live, attenuated Listeria monocytogenes immunotherapy business, has entered into a organized collaboration with the laboratory of Dr. Tobias Kollmann at the University of British Columbia to build up live attenuated Listeria vaccines for the treatment of infectious disease and for new dosage forms of Listeria vaccines.Nearly 14 % of children in the usa between your ages of 2 and 17 have already been exposed to some form of disaster, the report showed. This includes natural disasters like earthquakes, fires, floods and disease outbreaks, in addition to man-made disasters such as industrial accidents, terrorism and war acts. Adjustment problems among kids who’ve experienced an emergency or lived through a disaster are a significant public ailment, the academy cautioned. But these children often show no visible signs of problems.